Literature DB >> 2816420

[Antidiarrheal and anti-inflammatory effects of berberine].

M F Zhang, Y Q Shen.   

Abstract

Berberine sulfate (Ber) 40 and 80 mg/kg ig reduced the purging effects of castor oil or Cassia angustifolia leaf in mice, but did not affect the gastrointestinal transport function of Chinese ink in normal mice. Ber 60 mg/kg ig significantly inhibited the increased vascular permeability induced by ip 0.7% acetic acid in mice. Ber 20 and 50 mg/kg sc markedly inhibited the increased vascular permeability induced by histamine 100 micrograms/0.1 ml ic in rats. Ber 4 and 8 mg/kg sc produced obvious inhibition in the xylene-induced swelling of mouse ear. The anti-inflammatory effects were enhanced in a dose-dependent manner. It is suggested that the antidiarrheal effect of Ber is relative to its restriction against exudative inflammation to a certain extent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816420

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  4 in total

1.  Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.

Authors:  Xiao-Yan Lv; Jing Li; Ming Zhang; Chun-Mei Wang; Zheng Fan; Chun-Yan Wang; Li Chen
Journal:  AAPS PharmSciTech       Date:  2010-03-17       Impact factor: 3.246

2.  Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.

Authors:  Ming Zhang; Xiaoyan Lv; Jing Li; Zhaojie Meng; Qiujing Wang; WenGuang Chang; Wei Li; Li Chen; Yanjun Liu
Journal:  Mol Cell Endocrinol       Date:  2012-08-16       Impact factor: 4.102

3.  Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.

Authors:  Shengnan Wei; Ming Zhang; Yang Yu; Xiaoxin Lan; Fan Yao; Xin Yan; Li Chen; Grant M Hatch
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

4.  Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.

Authors:  Beth Buchanan; Qingfang Meng; Mathieu-Marc Poulin; Jonathan Zuccolo; Chike Godwin Azike; Joseph Gabriele; David Charles Baranowski
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.